Health
A progress check. Multiple Sclerosis.
Written by Trevis Gleason Monday, 11 June 2007 20:13
It has been a few months now since the re-introductions of Tysabri (natalizumab) back into the U.S. market. The passion with which many MS patients urged the FDA’s panel making the decision was unprecedented. Powerful to the point that, for only the second time in the agency’s history, a drug pulled for safety concerns was allowed for continued use.
The MS community, doctors and even the stock market annalists were excited to have this powerful new drug once again allowed. The ...
Page 1 of 1
- Start
- Prev
- 1
- Next
- End
